Human Menopausal Gonadotropin
HMG
Human Menopausal Gonadotropin combination of FSH and LH in a 1:1 ratio that is extracted from urine obtained from postmenopausal women, widely used for Controlled Ovarian stimulation to stimulate the recruitment and development of multiple eggs during an ovulation induction cycle in women undergoing Assisted Reproductive Technology (ART) like IUI, IVF and ICSI.
.
HMG
Human Menopausal Gonadotropin combination of FSH and LH in a 1:1 ratio that is extracted from urine obtained from postmenopausal women, widely used for Controlled Ovarian stimulation to stimulate the recruitment and development of multiple eggs during an ovulation induction cycle in women undergoing Assisted Reproductive Technology (ART) like IUI, IVF and ICSI.
Therapeutic Uses of HMG:
- Used for Ovulation Induction/Controlled Ovarian stimulation in infertile women as part of
- Assisted Reproductive
- Technology (IUI / In-Vitro Fertilization (IVF)/ ICSI treatment)
- Used for Spermatogenesis - Hypogonadotrophic hypogonadism in men
Formulations/Strengths:
- Lyophilized (Single dose vials): 75 IU & 150 IU
- Liquid Form Multi-dose Vials: 600 IU & 1200 IU
Available in:
- Lyophilized form (to be reconstituted) and
- The liquid form (Ready to use) Single & Multi-dose Vials;
Method of Administration:
- Intramuscular or subcutaneous use by registered practitioners only
DISCLAIMER: †GYNOGENTM is a trademark of Sanzyme Private Limited excluding India. This disclosure does not intend to market and commercialize GYNOGENTM in India but for export purposes only.
Visited 563 times, 1 visit(s) today
Since 1969, when we entered into a Joint Venture with Sankyo (now Daiichi-Sankyo) to make gonadotropins to export to Japan, we’ve been at the forefront of biological hormones, and today we have the necessary technological foundation to do path breaking work.